122 related articles for article (PubMed ID: 9297316)
1. [Towards screening for Chlamydia trachomatis].
Kolmos HJ
Ugeskr Laeger; 1997 Aug; 159(34):5104-5. PubMed ID: 9297316
[No Abstract] [Full Text] [Related]
2. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Ruitenberg EN
Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
[No Abstract] [Full Text] [Related]
3. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
Habets PC
Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
[No Abstract] [Full Text] [Related]
4. Chlamydia trachomatis: common misperceptions and misunderstandings.
Stevens-Simon C; Sheeder J
J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):231-43. PubMed ID: 16171726
[No Abstract] [Full Text] [Related]
5. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
[TBL] [Abstract][Full Text] [Related]
6. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
Nyári T; Mészáros G; Deák J; Nagy E; Kovács L
Orv Hetil; 2000 Jul; 141(27):1511-6. PubMed ID: 10943109
[TBL] [Abstract][Full Text] [Related]
7. Is Europe ready for STD screening?
Mårdh PA
Genitourin Med; 1997 Apr; 73(2):96-8. PubMed ID: 9215088
[No Abstract] [Full Text] [Related]
8. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
[TBL] [Abstract][Full Text] [Related]
9. [Screening for Chlamydia trachomatis infection: which target group and at what price?].
Postma MJ; van den Hoek JA
Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1237-8. PubMed ID: 10428675
[No Abstract] [Full Text] [Related]
10. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
[TBL] [Abstract][Full Text] [Related]
11. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home.
Novak DP; Lindholm L; Jonsson M; Karlsson RB
Scand J Public Health; 2004; 32(5):324-32. PubMed ID: 15513664
[TBL] [Abstract][Full Text] [Related]
12. The silent epidemic of Chlamydia: what are we missing here?
Sanfilippo JS
J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):231-2. PubMed ID: 18794016
[No Abstract] [Full Text] [Related]
13. [Chlamydia trachomatis: should it be systematically be screened or treated? Literature review and cost/benefit estimation in France].
Henry-Suchet J; Sluzhinska A; Serfaty D
Contracept Fertil Sex; 1998 Feb; 26(2):151-8. PubMed ID: 9560916
[TBL] [Abstract][Full Text] [Related]
14. The chlamydia problem in New Zealand.
Perkins N
N Z Med J; 2004 May; 117(1194):U887. PubMed ID: 15156205
[No Abstract] [Full Text] [Related]
15. Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approaches.
Postma MJ; Welte R; van den Hoek JA; Morré SA
Sex Transm Infect; 2002 Feb; 78(1):73-4. PubMed ID: 11872873
[No Abstract] [Full Text] [Related]
16. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infection in women.
Gupta M; Hernon M; Gokhale R; Ghosh AK
Sex Transm Infect; 2002 Feb; 78(1):76. PubMed ID: 11872877
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
Blake DR; Gaydos CA; Quinn TC
Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
[TBL] [Abstract][Full Text] [Related]
18. High cost of Chlamydia can be cut, researcher finds.
Silversides A
CMAJ; 1999 Apr; 160(8):1119. PubMed ID: 10234330
[No Abstract] [Full Text] [Related]
19. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
20. Screening for Chlamydia trachomatis; the Amsterdam experience.
Bleker OP
Minerva Ginecol; 2000 Dec; 52(12 Suppl 1):97-9. PubMed ID: 11526697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
